We have demonstrated that 4SC-202 inhibits osteosarcoma cell growth in vitro and in vivo, and advanced our understanding of the key roles of HDAC1, HDAC2, and HDAC3 in the biological behaviors of osteosarcoma. Here, HDAC3 is linked to osteosarcoma.